| |
|
|
Korea United Pharm. Inc. (033270) |
|
|
STOCK |
|
|
| Address |
404-10,NOJANG-RI, JEONDONG-MYEON, YEONGI-GUN, CHUNGNAM |
| Home Page |
www.kup.co.kr
|
| Established |
1987.12. 3 |
Tel |
041-862-5030 |
| Listed |
2007.10.23 |
IR |
02-516-3041 |
| Common shares O/S |
15,025,924 |
President |
Kang,Duk Young |
| Preferred shares O/S |
|
No.of Employees |
286(2008. 9) |
| Sales increased steadily on rising demand for its key products such as digestives and pain relievers. Its profitability improved on reduced administrative costs and reduced costs of raw materials. The company is seeking to develop a series of new drugs. |
| In 2008, the company plans to unveil 16 new drugs and 20 more in 2009. Sales are forecast to increase on strong sales of new drugs. Its financial status is expected to remain stable on good cash flows. |
|
  |
(date: 2008.06, unit : %) |
| Name |
Kang Deogyeong |
Kim Gwija |
Kang Yena |
| Portion |
45.3 |
0.7 |
0.0 |
|
 |
(unit : %) |
| Sales |
Antibiotics |
33.1 |
Cost |
Raw Materials |
|
| Cycling Machine |
11.7 |
Labors |
|
| Gastrointestinal System Drugs |
11.7 |
Overhead |
|
|
 |
(Unit : 100Mn.Won,Won) |
| Year |
07.10 |
- |
- |
- |
- |
| Type |
LI |
- |
- |
- |
- |
| Amount |
75.13 |
- |
- |
- |
- |
|
|
|
|
